Spiperone hydrochloride

Discontinued Product

Spiperone hydrochloride (Cat. No. 0995) has been withdrawn from sale for commercial reasons.
Description: 5-HT2A antagonist; also D2-like antagonist
Chemical Name: 8-[4-(4-Fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4,5]decan-4-one hydrochloride
Purity: ≥98% (HPLC)
Datasheet
Citations (6)
Reviews
Literature (3)

Biological Activity for Spiperone hydrochloride

Spiperone hydrochloride is a 5-HT2A serotonin and selective D2-like dopamine receptor antagonist (Ki values are 0.06, 0.6, 0.08, ~ 350, ~ 3500 nM for D2, D3, D4, D1 and D5 receptors respectively). Antipsychotic.

Technical Data for Spiperone hydrochloride

M. Wt 431.94
Formula C23H26FN3O2.HCl
Storage Store at RT
Purity ≥98% (HPLC)
CAS Number 2022-29-9
PubChem ID 11957687
InChI Key QUIKMLCZZMOBLH-UHFFFAOYSA-N
Smiles Cl.FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for Spiperone hydrochloride

Certificate of Analysis / Product Datasheet
Select another batch:

References for Spiperone hydrochloride

References are publications that support the biological activity of the product.

Hoyer et al (1994) VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol.Rev. 46 157 PMID: 7938165

Seeman and van Tol (1994) DA receptor pharmacology. TiPS 15 264 PMID: 7940991

Merck Index 12 8903

View Related Products by Product Action

View all 5-HT2A Receptor Antagonists

Keywords: Spiperone hydrochloride, Spiperone hydrochloride supplier, D2-like, antagonists, 5-HT2A, Dopamine, Non-Selective, Receptors, Serotonin, dopaminergic, Non-selective, 0995, Tocris Bioscience

6 Citations for Spiperone hydrochloride

Citations are publications that use Tocris products. Selected citations for Spiperone hydrochloride include:

Walory et al (2018) Oncotoxic Properties of Serotonin Transporter Inhibitors and 5-HT1A Receptor Ligands. Int J Mol Sci 19 PMID: 30347827

Baca et al (2013) Gene-environment interactions affect long-term depression (LTD) through changes in DA receptor affinity in Snap25 deficient mice. Brain Res 1532 85 PMID: 23939223

Titlow et al (2013) Pharmacological analysis of DA modulation in the Drosophila melanogaster larval heart. Physiol Rep 1 e00020 PMID: 24303109

Meredith et al (2006) DA targets cycling B cells independent of receptors/transporter for oxidative attack: Implications for non-Hodgkin's lymphoma. Proc Natl Acad Sci U S A 103 13485 PMID: 16938864


Reviews for Spiperone hydrochloride

There are currently no reviews for this product. Be the first to review Spiperone hydrochloride and earn rewards!

Have you used Spiperone hydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


5-HT Receptors Scientific Review

5-HT Receptors Scientific Review

Written by Nicholas M. Barnes and John F. Neumaier, this review summarizes the various serotonin receptor subtypes and their importance in mediating the role of serotonin in numerous physiological and pharmacological processes. Compounds available from Tocris are listed.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.